Feedback / Questions
COVID-19 antibody - IGM Biosciences
https://www.businesswire.com/news/home/20210111006077/en/AvantGen-Announces-Licensing-of-Its-Anti-SARS-CoV-2-Antibodies-to-IGM-Biosciences-for-COVID-19-Therapy-Development
 
Jan 11, 2021
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious